Kellogg's cereal business begins trading as standalone company W.K. Kellogg

  • 📰 NBCLA
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 59%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

As part of the separation, Kellogg has been renamed Kellanova but is still trading under the ticker “K.”

W.K. Kellogg, a spinoff of Kellogg's cereal business, began trading on the New York Stock Exchange.

As part of the separation, Kellogg has been renamed Kellanova but is still trading under the ticker"K." Shareholders received one share of W.K. Kellogg for every four shares of Kellogg they owned as of Sept. 21. Kellogg's cereal business began trading on the New York Stock Exchange at $13.80 per share as W.K. Kellogg after spinning off from its parent company on Monday morning.. It now houses snacking brands like Pringles and Cheez-It and its North American frozen-food unit, which includes Morningstar Farms.Get Southern California news, weather forecasts and entertainment stories to your inbox.Shares of Kellanova were down roughly 3% in morning trading, and W.K. Kellogg's stock fell 5%.

Shareholders received one share of W.K. Kellogg for every four shares of Kellogg they owned as of Sept. 21.the planned separation in June 2022. Cereal sales have stagnated as consumers choose from a wider variety of options for breakfast and prioritize convenience.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 319. in İD
 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boomKellogg, J.M. Smucker and other food companies are making big bets on snacking, but the rise of Wegovy and Ozempic could pose a threat to future sales growth.
Sumber: NBCLA - 🏆 319. / 59 Baca lebih lajut »